Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Toscano

Showing results (351-360 of 359) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 359 results.
Journal of Infection in Developing Countries|December 13, 2021
"I prefer to get coronavirus than to stop working": the street vendor's perspectiveJosuel Delgado-Enciso, Marina Delgado-Machuca, Karen A Mokay-Ramírez, et al.
Neurology|March 21, 2009
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population studyE Mercuri, S Messina, C Bruno, et al.
Orphanet Journal of Rare Diseases|July 9, 2016
MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patientsC Fiorillo, G Astrea, M Savarese, et al.
European Journal of Neurology|July 21, 2019
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP DatabaseP E Doneddu, E Bianchi, D Cocito, et al.
Brain : a Journal of Neurology|February 17, 2010
Multi-system neurological disease is common in patients with OPA1 mutationsP Yu-Wai-Man, P G Griffiths, G S Gorman, et al.
Research Square|September 16, 2020
Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled TrialIvan Delgado-Enciso, Juan Paz-Garcia, Carlos E Barajas-Saucedo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Experimental and Therapeutic Medicine|July 26, 2021
Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trialIvan Delgado-Enciso, Juan Paz-Garcia, Carlos E Barajas-Saucedo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
Pageof 36

Showing results (351-360 of 359) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 359 results.
Journal of Infection in Developing Countries|December 13, 2021
"I prefer to get coronavirus than to stop working": the street vendor's perspectiveJosuel Delgado-Enciso, Marina Delgado-Machuca, Karen A Mokay-Ramírez, et al.
Neurology|March 21, 2009
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population studyE Mercuri, S Messina, C Bruno, et al.
Orphanet Journal of Rare Diseases|July 9, 2016
MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patientsC Fiorillo, G Astrea, M Savarese, et al.
European Journal of Neurology|July 21, 2019
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP DatabaseP E Doneddu, E Bianchi, D Cocito, et al.
Brain : a Journal of Neurology|February 17, 2010
Multi-system neurological disease is common in patients with OPA1 mutationsP Yu-Wai-Man, P G Griffiths, G S Gorman, et al.
Research Square|September 16, 2020
Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled TrialIvan Delgado-Enciso, Juan Paz-Garcia, Carlos E Barajas-Saucedo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Experimental and Therapeutic Medicine|July 26, 2021
Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trialIvan Delgado-Enciso, Juan Paz-Garcia, Carlos E Barajas-Saucedo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
Pageof 36